The quest for cognitive immortality continues. Have you ever thought about what makes you? Science assures us it has everything to do with the three-pound organ between our ears, with its billions of neurons and trillions of delicate connections. But it's a lot trickier to explain why we have a sense of self-awareness or to pin down precisely where that first memory of Mommy actually resides. As we age, we forget most of what we've experienced, yet there's still undeniable continuity: At 30, or 50, or 70, you will still be you. To preserve that elusive continuity of self, some far-thinking technologists are working on ways to keep your brain going--even beyond death.

After four weeks of using the cream, participants lowered the biological age of their skin by about two years on average. A wave of biotech companies is looking to prove that it's possible to slow down the aging process. Mountain View, California-based Rubedo Life Sciences is starting with the most outwardly visible sign: the skin. The company's experimental treatment is showing early promise that it may be able to reduce the appearance of aging, according to data the company presented at the Aging Research and Drug Discovery meeting in Boston earlier this month. In a small clinical trial, Rubedo tested its topical cream on 11 people with atopic dermatitis, an inflammatory skin condition and the most common type of eczema.

Download this complimentary White Paper today! This White Paper gives robotics researchers and engineers an overview of a new large-scale motion capture dataset built to close the data gap limiting humanoid robot learning. It also shows how policies trained on the dataset transfer to a real humanoid robot.   What you will learn about:  Why humanoid robot learning, a central problem in embodied AI and Physical AI, needs data that internet video and existing motion capture datasets cannot provide.  How FrameNet, a linguistic framework for human action, can guide motion capture collection to systematically cover a broad range of whole-body motion.  Why synchronized object trajectories and meshes make human-object interaction data useful for teaching robots real-world tasks such as carrying, pushing, and pulling.  How reinforcement learning policies trained on this motion capture data improve with scale, and how sim-to-real transfer carries them onto a physical humanoid robot.    Click 'LOOK INSIDE' to Download Now.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Omar Sy on Lupin Season 4 and His'Stunned' Reaction to the Louvre Heist Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. The 6-foot-3 actor is sitting on a large leather sofa.

Plus: OpenAI has released 377 new math findings, further rattling the field. Popular weight-loss drugs may do more than help people shed pounds. They might also slow the aging process. Drugmakers Eli Lilly and Novo Nordisk say patients taking their GLP-1 drugs age less quickly, according to molecular "aging clocks" that track changes in DNA or levels of key proteins. The findings add to speculation that GLP-1 drugs could be acting on basic causes of aging and might be true longevity treatments. But how much can we read into these results?

Scientists say the fragrance industry will soon be able to reproduce scents and compounds from endangered plants without repeatedly harvesting them. Scientists say the fragrance industry will soon be able to reproduce scents and compounds from endangered plants without repeatedly harvesting them. Making scents: could AI help perfumers take pressure off endangered plants? M any of the world's most expensive perfumes begin with a wounded tree. When some trees are damaged, they produce a dark, fragrant resin that becomes agarwood, or oudh - an ingredient so valuable that wild trees have been illegally felled in its pursuit.

The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a "moral imperative" to address hereditary diseases. When the Chinese scientist He Jiankui announced in 2018 that he had created the first gene-edited babies, the experiment was widely condemned as reckless and premature. It ended with He in prison. But that hasn't stopped the push for gene-edited human embryos, with biotech entrepreneur Cathy Tie arguing that doing so isn't just urgent--it's a "moral imperative." Tie is the 30-year-old founder of Origin Genomics, a company that launched in March with plans to bring gene-edited embryos to IVF clinics.

Anthropic Says It Discovered a Crispr-Like System. "The experiments are still in the queue. The PR is already live," says one expert. Tech executives have long touted the potential for their AI models to accelerate the pace of biology discoveries. Last week, they announced one.

The Download: climate tech companies to watch and AI's discovery problem Plus: OpenAI has scrapped a new AI model over safety concerns. With the planet nearing 1.5 C of warming, climate policies being unraveled, and Big Tech backpedaling on its climate ambitions, it can be tempting to give in to climate doom and defeatism. But despite the headwinds, the world has still made incredible progress. That's why publishes its annual list of Climate Tech Companies to Watch . Once a year, we compile a list of 10 companies that we believe have done the most, or have the best chance, to make a real dent in emissions or improve public safety and health. We've now finalized our 2026 list and will publish it on October 6.

When can we say AI made a scientific discovery? AI companies' insistence that their technology is making breakthroughs, not just aiding scientists, is making real progress harder to recognize. Last Wednesday, Anthropic announced that earlier this year it had launched a molecular biology lab, where Claude agents read and conjecture about hard biology problems and human scientists run experiments on what they report. And this AI-powered lab, the company said, had made its first discovery. To understand what Anthropic says its system did, imagine you're flipping through a library of millions of DNA sequences, amassed as scientists sequence more and more of the living world. One step toward a breakthrough might be finding a peculiar sequence that encodes an interesting enzyme, perhaps.